Anti psychotics Disease Condition And Drugs Used For The Treatment Of this Disease And Their Action Of Mechanism.

1. Name:- Bhadani Smit Ramjibhai
Roll No.:- 17BPH095
Program:- B.Pharm
Sem.:- IV
Subject:- Pharmacology

2. 1. Definition :- Psychosis:-
2. Dopamine Hypothesis:-
3. Classification of Antipsychotics:-
4. Pharmacological Profile of Each Category:-
5. Clinical Usage:-

3. • A Symptom Of Mental illnesses.
• Characterised by Distorted or Non-Existent sense of Reality:-
- Hallucination.
- Delusions.
- Disorganised Speech.
- Disorganised or Agitated Behaviour.

4.  Mood Disorder (Major Depression or Mania With Psychotic Features).
 Substance Induced Psychosis.
 Dementia with Psychotic features.
 Delirium with Psychotic features.
 Schizophrenia.

5.  Put Forward by Arvid Carlsson.
 “The Clinical features Of Schizophrenia (Sometimes extended to
psychosis in General) is related to over activity of dopaminergic
function within the brain.”

6.  Typical/First Generation Antipsychotics:-
I. Phenothiazine Ex. :- Chlorpromazine
II. Butyraphenones Ex. :- Haloperidol
III. Thioxanthenes Ex. :-Flupentixol
 Atypical/Second Generation Antipsychotics:-
Ex. :- Clozapine , Risperidone , Olanzapine , Quetiapine , Aripiprazole.

7.  Mode Of Action :-
- Predominantly Act as antagonists at brain dopamine D2 receptors.
- Also Blocks
Muscarinic acetylcholine receptors
Antihistamine receptors
α adrenoceptors

9.  High rapid oral absorption.
 Highly lipophilic with high apparent volumes of distribution.
 Undergo extensive phase 1 metabolism by CYPs and
subsequent phase 2 conjugations.
 Excreted in the urine and to some extent in the bile.

10.  Extrapyramidal Motor Effects:-
 Due to dopamine D2 receptor blockade in the nigrostriatal
pathway (except tardive dyskinesia).
A. Acute dystonia
B. Akathisia
C. Parkinsonism
D. Tardive Dyskinesia

11.  Spasm of muscles of tongue, face, neck, back.
 High risk in- first few weeks, young, antipsychotic naive.

12.  Develops after months or years.
 In 20-40% of patients treated with first-
generation antipsychotic drugs.
 Often irreversible, often gets worse when
antipsychotic therapy is stopped.
 Elderly at 5-fold greater risk.

13.  Endocrine effects:-
Due to blockage of dopamine D2 receptors in tuberohypophyseal
pathway     Increased prolactin.:-
 Gynaecomastia.
 Agalactorrhea.
 amenorrhea in women.
 sexual dysfunction or infertility in men.

14.  Central antagonism of H1 receptors:-
a) Sedation.
b) Weight gain via appetite stimulation.
 Muscarinic antagonism -anticholinergic effects.
 1 Adrenergic antagonism - orthostatic hypotension.

15.  Adverse Cardiac Effects:-
Blockage of cardiac K+ channels
Prolong QT in ECG
Ventricular arrhythmia & sudden cardiac death.

16.  Increased risk for cerebrovascular events and all- cause
mortality in dementia patients.
 Lowers seizure threshold.
 Increased triglycerides.
 Hyperglycaemia.

17.  A fatal idiosyncratic ADR of antipsychotics.
 Characterized by,
1. Mental status changes.
2. Muscle rigidity.
3. Hyperthermia.
4. Autonomic dysfunction.

18. A. Typical/First Generation Antipsychotics:-
A. Phenothiazine e.g. chlorpromazine.
B. Butyraphenones e.g. haloperidol.
C. Thioxanthenes e.g. flupentixol.
B. Atypical/Second Generation Antipsychotics:-
e.g. Clozapine, Risperidone, Olanzapine, Quetiapine,
Aripiprazole.

19.  Mode of Action:-
Predominant antagonism of 5-HT2A receptors with a lesser
degree antagonism of dopamine D2 receptors.
 Has efficacy against negative symptoms esp. Clozapine.

21.  Extrapyramidal Motor Effects:-
 Considerably less compared to typical antipsychotics.
 Blockage of 5-HT2A receptors increase dopamine in striatum preventing
extrapyramidal effects.
 Cardiotoxicity:-
 Less associated with QT prolongation at therapeutic doses.

22.  High risk of new onset diabetes and diabetes ketoacidosis esp.
with clozapine and olanzapine.
 Agranulocytosis common with clozapine esp. in first 6 months
 regular FBC monitoring essential.

26.  Various disorders treated with antipsychotics in the elderly –
psychosis, bipolar affective disorder, delirium & dementia.
 Use extreme caution because of side effect profile.
 ‘Start low & go slow’ (Malone et al 2007) & titrate over longer periods
of time to reach the required dose.
 Avoid polypharmacy wherever possible.

27.  Avoid antipsychotics if possible.
 Use the lowest effective dose.
 Neonatal adverse effects observed include generalized hypertonicity
and dystonic reactions.

28.  The safety of atypical agents is yet to be established but preliminary reports
there to be no deleterious effects to the fetus.
 Isolated cases of congenital abnormalities with the use of Clozapine.
 No increased risk has emerged with the use of Olanzapine.
 The conventional agents are generally preferred.
 Supervised dose reduction and cessation 7-10 days prior to delivery should
be considered.

29.  Remember that antidepressant medication is only part of the
treatment for antenatal depression and anxiety. Also consider:-
 Psychological therapies.
 Exclude organic illness as a cause of mental health symptoms.
 Address any alcohol and/or illicit substance abuse.
 Assess the social situation.
 General lifestyle measures: adequate rest/sleep, balanced diet, exercise.
 The decision to treat should be made on an individual case basis.

30.  Conventional and atypical antipsychotics are used as the foundation for pharmacological
management of schizophrenia and related psychosis.
 All have equal efficacy, exception Clozapine.
 Atypical generally better tolerated & have less EPSE.
 Atypical first line treatment.
 Start lowest effective possible dose & titrate upwards.
 Ongoing monitoring & management of adverse effects.
 Caution numerous drug interaction & potential for neuroleptic malignant syndrome.